DK0636247T3 - Fremgangsmåde og sammensætning til reduktion af virkningerne af endogen alkalisk phosphatase - Google Patents

Fremgangsmåde og sammensætning til reduktion af virkningerne af endogen alkalisk phosphatase

Info

Publication number
DK0636247T3
DK0636247T3 DK94909759T DK94909759T DK0636247T3 DK 0636247 T3 DK0636247 T3 DK 0636247T3 DK 94909759 T DK94909759 T DK 94909759T DK 94909759 T DK94909759 T DK 94909759T DK 0636247 T3 DK0636247 T3 DK 0636247T3
Authority
DK
Denmark
Prior art keywords
alkaline phosphatase
composition
effects
reducing
endogenous alkaline
Prior art date
Application number
DK94909759T
Other languages
Danish (da)
English (en)
Inventor
Pratap Singh
Randy W Johnson
Original Assignee
Dade Behring Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Inc filed Critical Dade Behring Inc
Application granted granted Critical
Publication of DK0636247T3 publication Critical patent/DK0636247T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
DK94909759T 1993-02-17 1994-02-14 Fremgangsmåde og sammensætning til reduktion af virkningerne af endogen alkalisk phosphatase DK0636247T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1866193A 1993-02-17 1993-02-17
PCT/US1994/001906 WO1994019691A1 (fr) 1993-02-17 1994-02-14 Procede et composition permettant de reduire les effets de la phosphatase alcaline endogene

Publications (1)

Publication Number Publication Date
DK0636247T3 true DK0636247T3 (da) 1999-05-31

Family

ID=21789125

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94909759T DK0636247T3 (da) 1993-02-17 1994-02-14 Fremgangsmåde og sammensætning til reduktion af virkningerne af endogen alkalisk phosphatase

Country Status (10)

Country Link
US (1) US5948630A (fr)
EP (1) EP0636247B1 (fr)
JP (1) JP3350730B2 (fr)
AT (1) ATE170631T1 (fr)
AU (1) AU6247494A (fr)
CA (1) CA2118231A1 (fr)
DE (1) DE69412940T2 (fr)
DK (1) DK0636247T3 (fr)
ES (1) ES2123774T3 (fr)
WO (1) WO1994019691A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ524170A (en) * 2000-09-07 2004-08-27 Tokyo Gas Co Ltd Preparations for diagnosis of pancreatic exocrine function
US7888372B2 (en) * 2001-03-23 2011-02-15 National Institutes Of Health (Nih) Compositions and methods for modulating bone mineral deposition
JP4567326B2 (ja) * 2003-12-24 2010-10-20 三菱化学メディエンス株式会社 全血を用いる測定法
US7749722B2 (en) 2005-12-15 2010-07-06 Mitsubishi Kagaku Istron, Inc. Measuring method using whole blood
JP5137620B2 (ja) * 2007-04-03 2013-02-06 シスメックス株式会社 アルカリホスファターゼ標識検出用試薬キット、免疫測定用試薬キット及び免疫測定方法
EP1978363B1 (fr) 2007-04-03 2010-02-24 Sysmex Corporation Procédé de dosage immunologique, kit de réactif pour détecter la phosphatase alcaline, et kit réactif pour dosage immunologique
US20090104634A1 (en) * 2007-10-21 2009-04-23 Abbott Laboratories One-step immunoassays exhibiting increased sensitivity and specificity
CN110194774B (zh) * 2019-06-05 2021-12-28 苏州百灵威超精细材料有限公司 5，6-二氢-6-(2-萘基)咪唑并[2，1-b]噻唑草酸盐的制备方法
CN111289456B (zh) * 2020-03-31 2023-04-07 西安交通大学第二附属医院 一种检测粪便及肠道组织中肠碱性磷酸酶iap的方法
JP7714330B2 (ja) * 2020-09-08 2025-07-29 デンカ株式会社 偽陽性の抑制により特異性を改善した検査キット
JP7714329B2 (ja) * 2020-09-08 2025-07-29 デンカ株式会社 偽陰性の抑制により特異性を改善した検査試薬
CN113267390B (zh) * 2021-05-11 2023-05-05 北京丹大生物技术有限公司 一种用于滤纸干血片的检测标志物洗脱液及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325356A (en) * 1965-08-20 1967-06-13 Merck & Co Inc Compositions and method for treating helminthiasis
US4150141A (en) * 1977-06-28 1979-04-17 Johnson & Johnson Treatment for scabies
US4220153A (en) * 1978-05-08 1980-09-02 Pfizer Inc. Controlled release delivery system
US4517288A (en) * 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
US4543358A (en) * 1982-12-13 1985-09-24 American Cyanamid Company Anthelmintic gel composition and a method for their preparation at ambient temperatures
US4781920A (en) * 1984-11-13 1988-11-01 American Cyanamid Company Anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole
US5135847A (en) * 1988-11-18 1992-08-04 Becton, Dickinson And Company Substrate composition for alkaline phosphatase and method for assay using same
US5124245A (en) * 1989-02-09 1992-06-23 Eastman Kodak Company Wash composition, test kit and their use to determine a herpes simplex viral antigen
US5279935A (en) * 1990-03-01 1994-01-18 Becton, Dickinson And Company Method of immunossay including deactivation of endogenous alkaline phosphatase
US5250295A (en) * 1991-11-04 1993-10-05 The Regents Of The Univ. Of California Natural killer cell enhancing factor
US5478753A (en) * 1993-06-29 1995-12-26 Pb Diagnostic Systems, Inc. Positive calibrator/control composition for an IgM serology assay and an IgM serology assay

Also Published As

Publication number Publication date
JP3350730B2 (ja) 2002-11-25
US5948630A (en) 1999-09-07
ATE170631T1 (de) 1998-09-15
DE69412940D1 (de) 1998-10-08
WO1994019691A1 (fr) 1994-09-01
EP0636247B1 (fr) 1998-09-02
JPH07506437A (ja) 1995-07-13
ES2123774T3 (es) 1999-01-16
CA2118231A1 (fr) 1994-09-01
EP0636247A1 (fr) 1995-02-01
AU6247494A (en) 1994-09-14
DE69412940T2 (de) 1999-05-12

Similar Documents

Publication Publication Date Title
ATE214928T1 (de) Thrombininhibitoren
DE69528528D1 (de) Thrombin-inhibitoren
FI962315A0 (fi) Entsyymi-inhibiittorit
EE9900024A (et) Kajasummutaja mittelineaarlülitustele
ATE209191T1 (de) Parazinon thrombin inhibitoren
DE3866938D1 (de) Steroid-5-alpha-reduktase-inhibitoren.
NO942064D0 (no) yminhibitorer
DK0636247T3 (da) Fremgangsmåde og sammensætning til reduktion af virkningerne af endogen alkalisk phosphatase
TR199801361T2 (xx) Yeni ikameli imidazol bile�imleri.
FI965036L (fi) Interleukiini-beta:aa muuttavan entsyymin inhibiittoreita
WO1998045319A3 (fr) COMPOSES ET PROCEDES PERMETTANT D'INHIBER L'INTERACTION ENTRE L'α-CATENINE ET LA β-CATENINE
NO901111L (no) Korrosjonsinhibitor og fremgangsmaate ved anvendelse derav.
EE9800143A (et) Adaptiivse Kalmani filtri kasutamise meetod dünaamilistes süsteemides
ATE234091T1 (de) Thrombin inhibitoren
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
NO913025D0 (no) Anordning til innbyrdes forbindelse av stykker av samleskinner.
AU8218591A (en) Method for reducing interference in a fluorescent assay
NO911999L (no) Anvendelse av substituerte beta-hydroksyetylaminer som potente hemmestoffer til exoenzymer i sopp.
EE9800044A (et) Prolüülendopeptidaasi inhibiitorid
ES2186807T3 (es) Inhibidores de trombina.
DK0623614T3 (da) 4-aryl-4-hydroxy-tetrahydropyraner og 3-aryl-3-hydroxy-tetrahydrofuraner som inhibitorer for 5-lipoxygenase
BG100248A (bg) Инхибитори на скваленсинтетаза
HUP9901673A2 (hu) A politrauma utáni többszörös szervelégtelenség megakadályozására, valamint az extracorporeális vérkeringés utáni akut szerv károsodás megakadályozására szolgáló anti-szelektin antitestek
IT8448954A0 (it) Valvola,in particolare per impianti idraulici,e complesso di valvola che la include
ITRM930073A0 (it) Metodo di propagazione in vitro di cellule til.